EDGAR Filing Documents for 0001246360-12-002910

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001246360-12-002910

Filing Date

2012-06-29

Accepted

2012-06-29 19:35:10

Documents

Period of Report

2012-06-27

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	form.html	4
1	PRIMARY DOCUMENT	form.xml	4	3761
	Complete submission text file	0001246360-12-002910.txt		5355

Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421

Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900

SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 37 HANCOCK STREET BOSTON MA 02114

Business Address

WIRTH PETER (Reporting) CIK: 0001021041 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 12937161
SIC: 2836 Biological Products, (No Diagnostic Substances)